Tag: Infection

Biotech firm Eradivir raises $10.25M for Phase 2a EV25 study, aiming to revolutionize influenza treatment.

Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.

"New adware AdsExhaust targets Meta Quest users via SEO poisoning. Beware of downloading fake Oculus apps; it hijacks browsers and ...

A new info-stealing malware called 'Cheat Lab' is spreading by posing as a game cheat, tricking users into infecting their ...

Phage therapy, unlocking the potential of bacteria phages, is being used to treat antibiotic-resistant infections. It potentially saved a woman's ...

Discover the financial report of Theratechnologies Inc., a biopharmaceutical company specializing in healthcare therapies. Learn about their market cap, leadership ...

Scientists at Delft University of Technology have developed a revolutionary protein analysis technique with high sensitivity, enabling earlier disease detection ...

Ecolab reported strong Q4 sales growth driven by increased prices and new business opportunities in its institutional and specialty division. ...

T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...

Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...